Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
0.5140
+0.0338 (7.04%)
At close: Jul 25, 2025, 4:00 PM
0.5400
+0.0260 (5.06%)
After-hours: Jul 25, 2025, 7:59 PM EDT

Adial Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
87265724
Upgrade
Market Cap Growth
88.47%188.66%-60.76%-89.79%131.14%-1.60%
Upgrade
Enterprise Value
61205017
Upgrade
Last Close Price
0.511.011.865.3867.5042.50
Upgrade
PB Ratio
1.611.610.561.7616.126.14
Upgrade
P/TBV Ratio
3.821.610.561.7720.216.15
Upgrade
Debt / Equity Ratio
----0.07-
Upgrade
Quick Ratio
1.793.844.332.242.232.92
Upgrade
Current Ratio
1.994.164.902.672.373.41
Upgrade
Return on Equity (ROE)
-217.01%-323.80%-190.27%-318.27%-518.38%-195.80%
Upgrade
Return on Assets (ROA)
-107.38%-105.88%-82.24%-102.77%-170.58%-103.71%
Upgrade
Return on Capital (ROIC)
-131.95%-127.04%-116.98%-192.78%-285.36%-122.77%
Upgrade
Earnings Yield
-110.37%-201.82%-226.15%-220.51%-34.34%-44.52%
Upgrade
FCF Yield
-84.86%-105.86%-300.46%-193.74%-21.24%-31.20%
Upgrade
Buyback Yield / Dilution
-202.76%-240.54%-42.25%-34.69%-49.15%-26.50%
Upgrade
Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q